JPH08502035A - 試験管内受精を改良するための二成分フィブリングルー組成物 - Google Patents

試験管内受精を改良するための二成分フィブリングルー組成物

Info

Publication number
JPH08502035A
JPH08502035A JP6503912A JP50391294A JPH08502035A JP H08502035 A JPH08502035 A JP H08502035A JP 6503912 A JP6503912 A JP 6503912A JP 50391294 A JP50391294 A JP 50391294A JP H08502035 A JPH08502035 A JP H08502035A
Authority
JP
Japan
Prior art keywords
component
composition
fibrin glue
embryo
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP6503912A
Other languages
English (en)
Japanese (ja)
Inventor
バーニア、エフラチ
Original Assignee
オパーバス・ホールディング・ビー・ブイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オパーバス・ホールディング・ビー・ブイ filed Critical オパーバス・ホールディング・ビー・ブイ
Publication of JPH08502035A publication Critical patent/JPH08502035A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6503912A 1992-07-18 1993-07-09 試験管内受精を改良するための二成分フィブリングルー組成物 Ceased JPH08502035A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP92112295.8 1992-07-18
EP92112295 1992-07-18
EP93105298.9 1993-03-30
EP93105298 1993-03-30
PCT/EP1993/001797 WO1994002182A1 (fr) 1992-07-18 1993-07-09 Composition de colle fibrine a deux composants servant a ameliorer la fertilisation in vitro

Publications (1)

Publication Number Publication Date
JPH08502035A true JPH08502035A (ja) 1996-03-05

Family

ID=26131003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6503912A Ceased JPH08502035A (ja) 1992-07-18 1993-07-09 試験管内受精を改良するための二成分フィブリングルー組成物

Country Status (12)

Country Link
JP (1) JPH08502035A (fr)
KR (1) KR950702434A (fr)
AT (1) ATE151295T1 (fr)
AU (1) AU4566893A (fr)
CA (1) CA2140427A1 (fr)
CZ (1) CZ5495A3 (fr)
DE (1) DE69309685T2 (fr)
FI (1) FI950194A0 (fr)
HU (1) HUT71873A (fr)
IL (1) IL106293A0 (fr)
SK (1) SK5095A3 (fr)
WO (1) WO1994002182A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159469C (fr) * 1993-03-30 2004-06-22 Uri Martinowitz Colle fibrineuse a deux composants
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
WO1996003160A1 (fr) * 1994-07-26 1996-02-08 Children's Medical Center Corporation Suspension de cellules de fibrine pour la creation de nouveaux tissus
JPH11502431A (ja) * 1995-01-16 1999-03-02 バクスター インターナショナル インコーポレイテッド 手術後の癒着を防止するための架橋化フィブリンの自己支持シート様材料
ATE439150T1 (de) * 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
CH681693A5 (fr) * 1991-02-28 1993-05-14 Pentapharm Ag
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive

Also Published As

Publication number Publication date
DE69309685D1 (de) 1997-05-15
KR950702434A (ko) 1995-07-29
HU9500141D0 (en) 1995-03-28
IL106293A0 (en) 1993-11-15
WO1994002182A1 (fr) 1994-02-03
ATE151295T1 (de) 1997-04-15
FI950194A (fi) 1995-01-17
SK5095A3 (en) 1995-07-11
CZ5495A3 (en) 1995-06-14
AU4566893A (en) 1994-02-14
HUT71873A (en) 1996-02-28
FI950194A0 (fi) 1995-01-17
CA2140427A1 (fr) 1994-02-03
DE69309685T2 (de) 1997-10-16

Similar Documents

Publication Publication Date Title
AU678439B2 (en) Process for the obtention of a biological adhesive comprising fibrinogen, factor XIII and fibronectin
US5290918A (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5510102A (en) Plasma and polymer containing surgical hemostatic adhesives
AU593042B2 (en) Compositions and methods for the treatment of bleeding disorders
JPH07508275A (ja) 医療処置で用いるトロンビン血液分画
JP5268649B2 (ja) トロンビンを含まない生物学的接着剤及びその医薬としての使用
US6019993A (en) Virus-inactivated 2-component fibrin glue
WO1992013495A1 (fr) Adhesif a base de fibrinogene
JP2668762B2 (ja) 寒冷沈降物を用いて製造した改良組織接着剤
IE890269L (en) Composition of anticoagulants
US7371722B2 (en) Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
CA1338698C (fr) Methode de preparation d'une solution a haute concentration d'une proteine activateur tissulaire du plasminogene; solution renfermant une proteine de ce type et son utilisation enmedecine humaine et veterinaire
NO329232B1 (no) Medikament for lokal paforing og framgangsmate for framstilling av en fibrinogenholdig losning
DK1837039T3 (en) Tissue adhesives, containing fibrinogen, to prevent tissue adhesion.
JPH08502035A (ja) 試験管内受精を改良するための二成分フィブリングルー組成物
Mitrakul Effects of green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: studies in vivo and in vitro
EP0651659B1 (fr) Composition de colle fibrine a deux composants servant a ameliorer la fertilisation in vitro
Lewis et al. Intraoperative coagulation changes in liver transplantation
Ratnoff A. The Physiology of Blood Coagulation
Van Lancker et al. Blood Coagulation

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040113

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20040524

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040629